Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial

N. Pelletier-Fleury, N. Meslier, F. Gagnadoux, C. Person, D. Rakotonanahary, H. Ouksel, B. Fleury, J. L. Racineux (Le Kremlin Bicetre, Paris, France)

Source: Annual Congress 2003 - Management of sleep related breathing disorders
Session: Management of sleep related breathing disorders
Session type: Oral Presentation
Number: 2240
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Pelletier-Fleury, N. Meslier, F. Gagnadoux, C. Person, D. Rakotonanahary, H. Ouksel, B. Fleury, J. L. Racineux (Le Kremlin Bicetre, Paris, France). Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial. Eur Respir J 2003; 22: Suppl. 45, 2240

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Randomized trial of oropharyngeal exercises plus incentive spirometry on patients with mild to moderate obstructive sleep apnea syndrome
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018



Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials.
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017


Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Efficacy of mandibular advancement appliance in moderate obstructive sleep apnea syndrome. A prospective randomised study
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010


Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018
Year: 2018



Validity of a new postural device for the treatment of patients with positional obstructive sleep apnea. A randomized control study.
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019


Long-term efficacy of motivational interviewing on improving continuous positive airway pressure adherence in obstructive sleep apnea: A randomized controlled trial
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019




Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Assessing an auto set trial period for obstructive sleep apnoea patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019